Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

31.64
+0.91002.96%
Post-market: 31.640.00000.00%16:40 EDT
Volume:576.17K
Turnover:18.20M
Market Cap:2.43B
PE:-9.84
High:32.01
Open:30.91
Low:30.74
Close:30.73
Loading ...

Director Steven Gannon Reports Disposal of Common Shares in Xenon Pharmaceuticals Inc

Reuters
·
9 hours ago

Xenon Pharmaceuticals Inc. Held Annual Shareholders Meeting

Reuters
·
Yesterday

Xenon Pharmaceuticals to Present at Global Healthcare Conference

TIPRANKS
·
04 Jun

Xenon Pharmaceuticals Inc. Announces Inducement Grants for New Employees Under 2025 Equity Incentive Plan

Reuters
·
31 May

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
31 May

Stock Track | Xenon Pharmaceuticals Plummets 12.59% as Q1 Losses Widen Despite Revenue Beat

Stock Track
·
16 May

Xenon Pharmaceuticals Initiated at Outperform by Evercore ISI Group

Dow Jones
·
15 May

Stock Track | Xenon Pharmaceuticals Plummets 12.59% as Q1 Losses Widen Despite Revenue Beat

Stock Track
·
13 May

Stock Track | Xenon Pharmaceuticals Plummets 12.59% as Widening Q1 Losses Overshadow Revenue Beat

Stock Track
·
13 May

Xenon Pharmaceuticals Price Target Maintained With a $53.00/Share by HC Wainwright & Co.

Dow Jones
·
13 May

Xenon Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
13 May

RBC Adjusts Price Target on Xenon Pharmaceuticals to $55 From $58, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
13 May

Stock Track | Xenon Pharmaceuticals Plunges 6.53% Pre-Market Despite Better-Than-Expected Q1 Results

Stock Track
·
13 May

Stock Track | Xenon Pharmaceuticals Plunges 6.53% Pre-market Following Q1 Earnings Report

Stock Track
·
13 May

Xenon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Xenon Pharmaceuticals Reports Q1 2025 Results and Advances Clinical Pipeline

TIPRANKS
·
13 May

Xenon Pharmaceuticals Q1 Loss Widens; Shares Drop

MT Newswires Live
·
13 May

Xenon Pharmaceuticals Q1 EPS $(0.83) Beats $(0.92) Estimate, Sales $7.50M Beat $1.11M Estimate

Benzinga
·
13 May

BRIEF-Xenon Pharmaceuticals Q1 Net Income USD -65.047 Million Vs. IBES Estimate USD -72.5 Million

Reuters
·
13 May

Xenon Pharmaceuticals Reports Q1 2025 Revenue Surge to $7.5M; Net Loss Widens to $65M

Reuters
·
13 May